Discussing Cervical Cancer Screening Options: Outcomes to Guide Conversations Between Patients and Providers

Purpose. In 2018, the US Preventive Services Task Force (USPSTF) endorsed three strategies for cervical cancer screening in women ages 30 to 65: cytology every 3 years, testing for high-risk types of human papillomavirus (hrHPV) every 5 years, and cytology plus hrHPV testing (co-testing) every 5 yea...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:MDM Policy Pract
Autori principali: Holt, Hunter K., Kulasingam, Shalini, Sanstead, Erinn C., Alarid-Escudero, Fernando, Smith-McCune, Karen, Gregorich, Steven E., Silverberg, Michael J., Huchko, Megan J., Kuppermann, Miriam, Sawaya, George F.
Natura: Artigo
Lingua:Inglês
Pubblicazione: SAGE Publications 2020
Soggetti:
Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC7440733/
https://ncbi.nlm.nih.gov/pubmed/32885045
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/2381468320952409
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi